The Latest Cardiac and Vascular News
Westport, CT, July 25, 2023 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced the completion of a seed funding round raising $2.2 million for BioSig AI Sciences, Inc. (“BAIS”), a subsidiary of the […]
MINNEAPOLIS, July 25, 2023 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the second quarter of 2023. Recent Highlights Total revenue for the […]
DALLAS, July 25, 2023 /PRNewswire/ — Dynamic Access, LLC (Dynamic), a leading provider of outsourced vascular access services, has announced the acquisition of Priority PICC Solutions, LLC (Priority) based in Chicago, Illinois. Priority has been providing expert services to healthcare facilities in Chicago and surrounding areas since 2008 under the direction of its founders and owners, Mary Santiago and Dr. Julio […]
THE WOODLANDS, Texas and REGENSBURG, Germany, July 25, 2023 /PRNewswire/ — The US Food and Drug Administration has cleared a Numares Health test, the AXINON® LDL-p Test System, as a new tool physicians can use to measure lipoproteins for patients at risk for cardiovascular disease. Currently, Numares is the only company in the US selling an FDA-cleared […]
BILLERICA, Mass.–(BUSINESS WIRE)– Access Vascular, Inc. (AVI), a medical device company addressing the most common and costly complications of intravenous therapy, today announced the publication of a peer-reviewed study of its HydroPICC® peripherally inserted central catheter (PICC) in the journal Journal of Materials Science: Materials in Medicine. The retrospective study demonstrated that HydroPICC significantly […]
DENVER – JULY 18, 2023 — Cleerly, the company on a mission to eliminate heart attacks by creating a new standard of care for heart disease, today announced a partnership with Cenegenics, a leading performance health age management platform dedicated to helping people achieve their peak cognitive, physical and metabolic health. Through […]
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced the appointment of Lorinda Burgess to the Company’s Board of Directors. “Her extensive […]
CARLSBAD, Calif., July 24, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its second quarter 2023 financial results on Monday, August 7, 2023. In conjunction with the […]
SUNNYVALE, Calif., July 24, 2023 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announces that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the ongoing Phase III pivotal CardiAMP® Cell Therapy Heart […]
Basel, 24 July 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today a new partnership with Alnylam to develop and commercialise zilebesiran, an investigational RNAi therapeutic currently in Phase 2 for the treatment of hypertension. Hypertension affects more than 1.2 billion adults worldwide and is the main, independent, preventable […]
